Cargando…

PO-1494 Universal testing for SARS-Cov-2 in patients undergoing anticancer treatment.

Detalles Bibliográficos
Autores principales:	Guerini, A.E., Magrini, S.M., Borghetti, P., Volpi, G., Luca, T., Costa, L., Pegurri, L., Guaineri, A., Imbrescia, J., Ranghetti, E., Premi, A., Donofrio, A., Spiazzi, L., Buglione, M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ireland Ltd. 2021
Materias:	Digital Poster: Other
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479304/ http://dx.doi.org/10.1016/S0167-8140(21)07945-7

Ejemplares similares

RR Myelo POINT: A Retrospective Single-Center Study Assessing the Role of Radiotherapy in the Management of Multiple Myeloma and Possible Interactions with Concurrent Systemic Treatment
por: Guerini, Andrea Emanuele, et al.
Publicado: (2022)

The potential role of SPECT/CT in the clinical management of COVID-19 lung cancer patients undergoing radiotherapy
por: Borghetti, Paolo, et al.
Publicado: (2021)

Differential Diagnosis and Clinical Management of a Case of COVID-19 in a Patient With Stage III Lung Cancer Treated With Radio-chemotherapy and Durvalumab
por: Guerini, Andrea Emanuele, et al.
Publicado: (2020)

Adoption of Hybrid MRI-Linac Systems for the Treatment of Brain Tumors: A Systematic Review of the Current Literature Regarding Clinical and Technical Features
por: Guerini, Andrea Emanuele, et al.
Publicado: (2023)

PO-1528 Mood disorder in cancer patients undergoing radiotherapy during the COVID-19 outbreak
por: Nardone, V., et al.
Publicado: (2021)

Two months of radiation oncology in the heart of Italian “red zone” during COVID-19 pandemic: paving a safe path over thin ice
por: Buglione, Michela, et al.
Publicado: (2020)

PO-1179 Radiation induced pneumonitis during COVID-19: artificial intelligence for differential diagnosis.
por: Ippolito, E., et al.
Publicado: (2021)

PO-1524 On how COVID-19 has affected radiation therapy treatments
por: Ambroa Rey, E.M., et al.
Publicado: (2021)

PO-1476 Covid-19 era and radiotherapy: psychological changes in oncological patients
por: Caliandro, M., et al.
Publicado: (2021)

PO-1059 The contribution of hypofractionated radiotherapy during the COVID 19 pandemic
por: Dhouib, F., et al.
Publicado: (2022)

PO-1070 Impact of COVID-19 in cancer patients: Analysis of the first 20 months in 13 Spanish Centers
por: Romero, S., et al.
Publicado: (2022)

PO-1514 Prospective assessment of employees stress during the COVID-19 pandemic
por: Guckenberger, M., et al.
Publicado: (2021)

PO-1060 Survival Analysis for Whole Lung Radiation in Patients with Acute Respiratory Syndrome for COVID-19
por: Ortiz Arce, C.S., et al.
Publicado: (2022)

PO-1505 Phone call triage for patients admission in a radiotherapy department during COVID 19 pandemic
por: Santo, B., et al.
Publicado: (2021)

PO-1506 Psychological impact of COVID 19 pandemic in cancer patients: a cross sectional observational study
por: SANTO, B., et al.
Publicado: (2021)

Three weekly versus weekly concurrent cisplatin: safety propensity score analysis on 166 head and neck cancer patients
por: Buglione, Michela, et al.
Publicado: (2021)

PO-1420 iCARE: sarcoma patient radiotherapy experience during COVID-19
por: McCabe, H., et al.
Publicado: (2021)

PO-1249 The impact of COVID-19 pandemic in the lung cancer treatment in a radiotherapy service
por: Costa, S., et al.
Publicado: (2022)

PO-1165 Dosimetric parameters in hypofractionated radiotherapy in NSCLC cohort during SARS-COV-2 pandemia
por: González Ruiz, M.A., et al.
Publicado: (2021)

PO-1181 Hypofractionation in NSCLC as the new standard of care during SARS-CoV-2 pandemia.
por: Vera Barragán, V., et al.
Publicado: (2021)

PO-1198 Changes in radical radiotherapy for lung cancer patients in the UK during the COVID-19 pandemic.
por: croxford, W., et al.
Publicado: (2021)

PO-1484 Impact of COVID-19 pandemic on Radiation Oncology practice. An overview of recent higher quality reports
por: Carbonara, R., et al.
Publicado: (2021)

PO-1453 Psychological impact of COVID-19 to patients undergoing radiation therapy
por: Oualha, A., et al.
Publicado: (2022)

PO-1174 3-weekly paclitaxel-carboplatin with radiation for stage III NSCLC – option during COVID-19 pandemic
por: Wong, H., et al.
Publicado: (2021)

PO-1473 Effectiveness and tolerability of SARS-CoV-2 vaccination in patients undergoing radiotherapy
por: Geinitz, H., et al.
Publicado: (2022)

PO-1517 Which impact of the COVID-19 pandemic on residents training in radiotherapy?
por: Fourati, N., et al.
Publicado: (2021)

PO-1561 Low Dose Radiation Therapy for COVID-19 Pneumonia: Risk of Cancer with AP-PA fields and IMRT
por: Sharma, D.N., et al.
Publicado: (2022)

Tele-Audiology: Current State and Future Directions
por: D'Onofrio, Kristen L., et al.
Publicado: (2022)

PO-1100 Implementation of FAST-Forward during COVID19: Report of acute skin toxicity /resource implications
por: Nugent, K., et al.
Publicado: (2021)

PO-1058 Estimating the carbon footprint of the radiotherapy pathway and changes in response to COVID-19
por: Cummings, J., et al.
Publicado: (2022)

PO-1480 Implementation of a self-administered patient health history questionnaire in a radiation oncology department during COVID-19.
por: Houlihan, O., et al.
Publicado: (2021)

Chemo-radiotherapy plus durvalumab for loco-regional relapse of resected NSCLC
por: Borghetti, Paolo, et al.
Publicado: (2022)

PO-1453 Covid-19 pandemic adapted radiotherapy guidelines: are they really followed?
por: Galofaro, E., et al.
Publicado: (2021)

Whole brain radiotherapy with adjuvant or concomitant boost in brain metastasis: dosimetric comparison between helical and volumetric IMRT technique
por: Borghetti, Paolo, et al.
Publicado: (2016)

PO-1000 Any impact of COVID-19 pandemic on the features of the Head and Neck (HN) cancer patients?
por: Yanes, B., et al.
Publicado: (2021)

PO-0951 Effects of COVID-19 during radio(chemo)therapy in head and neck cancer patients
por: Bandurska-Luque, A., et al.
Publicado: (2021)

Early results of PRO-EPI: PROspective multicenter observational study on elective pelvic nodes irradiation in patients with intermediate/high/very high-risk non-metastatic prostate cancer submitted to radical, adjuvant, or salvage radiotherapy with or without concomitant androgen deprivation therapy
por: Guerini, Andrea Emanuele, et al.
Publicado: (2022)

C1494T mitochondrial dna mutation, hearing loss, and aminoglycosides antibiotics
por: Postal, Mariana, et al.
Publicado: (2015)

P1494: EFFECT OF IRON DEFICIENCY ANEMIA ON PROPRIOCEPTION IN ADULT WOMEN
por: Mezghani, Ines, et al.
Publicado: (2023)

1494P Anxiety and depression during the COVID-19 pandemic in newly diagnosed advanced cancer patients
por: Obispo, B., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vq198qre6rt6tmns9hmh8ceaui